Medical Science Liaison
Thermo Fisher ScientificSalary not specified
Not SpecifiedCompensation
N/AExperience Level
N/AJob Type
Not SpecifiedVisa
N/AIndustries
Requirements
- Advanced degree in life sciences (PharmD, PhD, MD/DO, MSN, NP/DNP, DMS/PA or equivalent) is required
- Minimum of 5 years relevant clinical and/or industry experience required, experience in Dermatology strongly preferred
- Prior experience as a field medical science liaison required, experience in Dermatology preferred
- Relevant therapeutic area knowledge, comprehensive understanding of drug development process, clinical trial design, safety monitoring, and regulatory landscape in the pharmaceutical/biotechnology industry
- Self-driven and ability to work independently with minimal direct supervision
- Exceptional communication and time management skills
- Must live within applicable territory with convenient access to national/international airport
Responsibilities
- Identify, develop, and maintain collaborative relationships with current and future national and regional key opinion leaders, speakers and investigators through meaningful scientific exchange
- Stay informed of medical and scientific developments in Dermatology and related fields by continuously reviewing relevant literature, monitoring competitor activities, networking with experts, and attending relevant conferences
- Support national and regional scientific congresses with KOL engagements, poster /abstract coverage, booth staffing, and company debriefs
- Provide internal stakeholders with feedback and actionable insights from interactions and discussions with HCPs
- Identify, engage, and support investigators and site staff of high-impact, high-performing clinical research sites for Oruka’s clinical development programs
Skills
Abata Therapeutics
Develops therapies for autoimmune diseases
About Abata Therapeutics
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.
Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees
Risks
Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.
Differentiation
Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.
Upsides
Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.
Related Jobs
RemoteRemoteClinical Science - Medical Science Liaison (Sr.)
TempusSalary not specified
RemoteScientific Business Analyst, Scientific AI
TetraScienceSalary not specified
Full Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
RemoteDirector, Medical Affairs
AbbottSalary not specified
RemoteMedical Writer, Scientific Communications
Penumbra IncSalary not specified
RemoteMedical Director - Medicaid (IL)
CVS HealthSalary not specified
- Full Time
- Senior (5 to 8 years)